Status | Study |
NOT_YET_RECRUITING |
Study Name: Pragmatic Research on Diuretic Management in Early BPD Pilot Condition: Date: 2023-06-01 Interventions: Furosemide is a loop diuretic that inhibits the reabsorption of sodium and chloride in the proximal and distal tubules as well as the loop of Henle. |
RECRUITING |
Study Name: Pragmatic Research on Diuretic Management in Early BPD Pilot Condition: Bronchopulmonary Dysplasia Date: 2023-06-01 Interventions: Furosemide is a loop diuretic that inhibits the reabsorption of sodium and chloride in the proximal and distal tubules as well as the loop of Henle. |
RECRUITING |
Study Name: Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease Condition: Bronchopulmonary Dysplasia Date: 2022-03-09 |
NOT_YET_RECRUITING |
Study Name: 129Xe MRI in Pediatric Population With BPD Condition: Bronchopulmonary Dysplasia Date: 2019-05-31 Interventions: All subjects will undergo hyperpolarized 129-Xenon MR imaging (HP MRI) and conventional proton MR imaging of lung.Hyperpolarized 129Xe gas is |
Not yet recruiting |
Study Name: Fluid Filled Lung Oxygenation Assistance Trial Condition: Bronchopulmonary Dysplasia Date: 2017-01-30 Interventions: Drug: Perfluorooctylbromide(PFOB) Subjects in the Perfluorooctylbromide (PFOB) Group will be administere |
Recruiting |
Study Name: Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2017-01-22 Interventions: Drug: Dexamethasone (Steroids) Is to describe the use of integrated assessment of respiratory physiology |
Recruiting |
Study Name: Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD) Condition: Bronchopulmonary Dysplasia Date: 2015-08-04 Interventions: Drug: Furosemide Cohort 1 furo |
Not yet recruiting |
Study Name: Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies Condition: Bronchopulmonary Dysplasia Date: 2015-05-04 Interventions: Biological: Mesenchymal Stem Cell (MSC) therapy 3 doses of 5 million MSC will be administered |
Active, not recruiting |
Study Name: Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study Condition: Bronchopulmonary Dysplasia Date: 2015-02-15 Interventions: Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells |
Recruiting |
Study Name: Transpyloric Feeding in Severe Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2014-05-15 Interventions: Other: transpyloric feeding Other: gastric |